Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease - PubMed (original) (raw)

. 1997 Apr;150(4):1349-60.

Affiliations

• PMID: 9094991
• PMCID: PMC1858188

Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease

P L Jones et al. Am J Pathol. 1997 Apr.

Abstract

Progressive pulmonary hypertension is characterized by smooth muscle cell proliferation and migration leading to occlusive arterial lesions. Previously, using cultured smooth muscle cells, we demonstrated that epidermal growth factor (EGF)-dependent proliferation and migration are dependent on tenascin-C (Tn) and cellular fibronectin (Fn), respectively. In this study we applied immunohistochemistry to lung biopsy tissue from patients with congenital heart defects and pulmonary hypertension to determine how the distribution and intensity of Tn, EGF, proliferating cell nuclear antigen (PCNA), and Fn expression related to arterial abnormalities. With mildly increased wall thickness, minimal Tn, PCNA, and EGF was evident. With progressive hypertrophy, moderately intense foci of Tn were apparent in the adventitia, periendothelium, and occasionally the media but not consistently co-distributing with EGF and PCNA. With obstructive lesions, intense neointimal Tn expression co-localized with EGF and PCNA. Fn accumulation in the periendothelium increased with medial hypertrophy and became more widespread in a diffuse pattern with neointimal formation. The neointima was predominantly composed of alpha-smooth-muscle-actin-positive cells, occasional inflammatory cells with no evidence of apoptosis. These studies are consistent with Tn modulating EGF-dependent neointimal smooth muscle cell proliferation and Fn providing a gradient for smooth muscle cell migration from media to neointima.

PubMed Disclaimer

Similar articles

• Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice.
  Yamamoto K, Onoda K, Sawada Y, Fujinaga K, Imanaka-Yoshida K, Shimpo H, Yoshida T, Yada I. Yamamoto K, et al. Cardiovasc Res. 2005 Feb 15;65(3):737-42. doi: 10.1016/j.cardiores.2004.10.034. Cardiovasc Res. 2005. PMID: 15664401
• Morphology of the internal elastic lamina in arteries from pulmonary hypertensive patients: a confocal laser microscopy study.
  Aiello VD, Gutierrez PS, Chaves MJ, Lopes AA, Higuchi ML, Ramires JA. Aiello VD, et al. Mod Pathol. 2003 May;16(5):411-6. doi: 10.1097/01.MP.0000067685.57858.D7. Mod Pathol. 2003. PMID: 12748246
• Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.
  Nishimura T, Vaszar LT, Faul JL, Zhao G, Berry GJ, Shi L, Qiu D, Benson G, Pearl RG, Kao PN. Nishimura T, et al. Circulation. 2003 Sep 30;108(13):1640-5. doi: 10.1161/01.CIR.0000087592.47401.37. Epub 2003 Sep 8. Circulation. 2003. PMID: 12963647
• [Pulmonary vascular remodelling. Considerations regarding the possible participation of growth peptides factors and related substances].
  Lopes AA, Aiello VD, Maeda NY, Ebaid M. Lopes AA, et al. Arq Bras Cardiol. 1993 Feb;60(2):107-14. Arq Bras Cardiol. 1993. PMID: 8240046 Review. Portuguese. No abstract available.

Cited by

• Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall.
  Trescher K, Thometich B, Demyanets S, Kassal H, Sedivy R, Bittner R, Holzinger C, Podesser BK. Trescher K, et al. Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):365-70. doi: 10.1093/icvts/ivt204. Epub 2013 May 8. Interact Cardiovasc Thorac Surg. 2013. PMID: 23656926 Free PMC article.
• Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia.
  Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, Kourembanas S. Minamino T, et al. Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8798-803. doi: 10.1073/pnas.161272598. Epub 2001 Jul 10. Proc Natl Acad Sci U S A. 2001. PMID: 11447290 Free PMC article.
• Immune and inflammatory mechanisms in pulmonary arterial hypertension.
  El Chami H, Hassoun PM. El Chami H, et al. Prog Cardiovasc Dis. 2012 Sep-Oct;55(2):218-28. doi: 10.1016/j.pcad.2012.07.006. Prog Cardiovasc Dis. 2012. PMID: 23009917 Free PMC article. Review.
• HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension.
  Kudryashova TV, Goncharov DA, Pena A, Kelly N, Vanderpool R, Baust J, Kobir A, Shufesky W, Mora AL, Morelli AE, Zhao J, Ihida-Stansbury K, Chang B, DeLisser H, Tuder RM, Kawut SM, Silljé HH, Shapiro S, Zhao Y, Goncharova EA. Kudryashova TV, et al. Am J Respir Crit Care Med. 2016 Oct 1;194(7):866-877. doi: 10.1164/rccm.201510-2003OC. Am J Respir Crit Care Med. 2016. PMID: 27119551 Free PMC article.
• Suppression subtractive hybridization identifies distinctive expression markers for coronary and internal mammary arteries.
  Qin M, Zeng Z, Zheng J, Shah PK, Schwartz SM, Adams LD, Sharifi BG. Qin M, et al. Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):425-33. doi: 10.1161/01.ATV.0000059303.94760.5C. Epub 2003 Jan 30. Arterioscler Thromb Vasc Biol. 2003. PMID: 12615697 Free PMC article.

References

1. 1. Circulation. 1978 Dec;58(6):1107-22 - PubMed
2. 1. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3509-13 - PubMed
3. 1. Cell. 1986 Oct 10;47(1):131-9 - PubMed
4. 1. J Cell Biol. 1987 Sep;105(3):1387-94 - PubMed
5. 1. Lab Invest. 1988 Feb;58(2):184-95 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal